Posts

Showing posts with the label Tourette Syndrome Treatment Market

Wesley Medical Research partnered with the University of Sydney in Australia for Tourette Syndrome Treatment Market

Image
  Increasing drug approval by regulatory authorities is projected to foster the growth of the Tourette syndrome treatment market. For instance, in October 2017, Neurocrine Biosciences Inc. announced that the Food Drug and Administration approved valbenazine orphan drug designation to treat pediatric patients with Tourette syndrome. Also, a growing partnership among key players for developing new treatments is again augmenting the growth of the market. For instance, in September 2017, Teva Pharmaceutical Industries and Nuvelution Pharma announced their partnership to develop AUSTEDO (deutetrabenazine) tablets for the treatment of tics which is associated with tourette syndrome in pediatric patients in the U.S. This partnership will drive the development of Austedo (deutetrabenazine) in Tourette syndrome by bringing new treatment options more quickly which are more necessary for the affected young patients. North America is expected to dominate the Tourette Syndrome Tre...

Popular posts from this blog

Vascular Ulcers Treatment focuses on keeping the wound site free of infection during the healing process and relieving edema

Hearing Protection Devices: Often Used To Prevent Noise-Induced Hearing Loss (NIHL)

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028